Cancer is the leading cause of death across the world and estimated to be the leading cause of burden of disease in Australia (Cancer Australia). Screening programs aim to reduce the incidence and mortality from cancer.
Improving cancer screening participation amongst our population within Australia’s three national cancer screening programs is a key priority for us.
BreastScreen NSW provides state-wide free screening mammography and assessment services.
BreastScreen NSW actively targets asymptomatic women aged 50 to 74 years for a free screening mammogram every 2 years. However, women over the age of 40 are also eligible to attend the service.
GP’s Role in BreastScreen NSW
GPs play an important role in providing support and encouragement to patients to participate in screening. BreastScreen NSW locations in our region include a permanent Sunflower clinic within Myer, Penrith Westfields and a Sunflower clinic at Blue Mountains Hospital in Katoomba.
Local Clinic Screening Services are currently available:
- MYER Penrith: 585 High St Penrith, NSW 2750 - Print poster.
- Blue Mountains: Blue Mountains Hospital, Ground Floor, Cnr Woodlands Road and Great Western Hwy, Katoomba - Print poster.
- Windsor: Hawkesbury Hospital Windsor from Wednesday 7 - Friday 23 April 2021. Print poster.
Call 132 050 or visit BreastScreen NSW to book.
Find out more about your role as a GP in BreastScreen NSW.
Breast Cancer Screening Resources
You can download information as well as posters and brochures to put in your waiting room.
National Bowel Cancer Screening Program
The National Bowel Cancer Screening Program (NBCSP) invites Australian’s between the ages of 50-74 to screen for bowel cancer at home using a free kit.
By 2020 all Australians aged between 50 and 74 years will be offered free screening every two years.
Eligible people are invited to complete an immunochemical Faecal Occult Blood Test (FOBT) from home and mail it to the program’s pathology laboratory for analysis at no cost to the patient.
GPs are encouraged to discuss bowel screening with patients aged 50 and over. Patients who receive a positive FOBT result are advised to contact their doctor to discuss results and any further tests.
GPs play a key role in ensuring that participants in the NBCSP progress through the screening pathways.
National Bowel Cancer Screening Results
National Bowel Cancer Screening Program participants will now have their bowel screening results uploaded to the My Health Record (MHR). When accessing bowel screening results through the MHR, participants will see a copy of the results letter they will have received from Sonic following testing of their returned samples. If participants do not have one of the new Participant Details form, they can handwrite on their form ‘Do not send reports to My Health Record’.
If a participant’s results are uploaded to the MHR and they want it removed, they can do this by logging into their MHR and removing the result; or contacting the MHR Helpline which is available 24/7 on 1800 723 471.
National Cancer Screening Register Supporting National Bowel Cancer Screening Program
From November 2019, the National Cancer Screening Register (the National Register) will begin supporting the National Bowel Cancer Screening Program
The Australian Government’s National Bowel Cancer Screening Program (NBCSP) is a population-based screening program, that aims to help detect bowel cancer early and reduce the number of Australians who die each year from the disease.
From 18 November 2019, the current NBCSP Register operated by the Department of Human Services, will transition over to the National Register to create a single national record for participants of the NBCSP and the National Cervical Screening Program (NCSP).
The National Register will support the NBCSP by:
- Collecting and storing NBCSP bowel cancer screening data.
- Inviting and reminding eligible people to participate (through integration with the Medicare database)
- Distributing iFOBT kits to eligible participants (a free test kit that can be completed at home and mailed to the contracted pathology laboratory for analysis).
- Providing the State and Territory Participant Follow-Up Function access to the National Register to facilitate their support and follow up of positive iFOBT results.
- Providing information on participants to healthcare providers.
- Providing reporting on key program and operational outcomes for policy makers and key stakeholders to ensure appropriate safety, monitoring and evaluation of the Program.
From March next year, extra features will be available:
- An online portal which will enable healthcare providers to access patient information and submit data electronically to the NBCSP and the NCSP.
- Integration with primary care Practice Management Software systems.
- Integration with whole-of-government services (e.g. MyGov, My Health Record) which will enable greater self-service options for people to manage their participation in both Programs.
From 18 November 2019, the National Register can be contacted for both NBCSP and NCSP-related purposes on the following:
- National Register Contact Centre:1800 627 701 (operates Monday to Friday, between 8am and 6pm in all Australian state and territory time zones)
- Fax: Bowel Screening Fax: 1800 115 062. Cervical Screening Fax: 1800 627 702
- Post: Bowel Screening Post: Reply Paid 90965, Sunshine VIC 3020. Cervical Screening Post: Reply Paid 90964, Sunshine VIC 3020
National Cervical Screening Program
The new National Cervical Screening Program commenced on 1 December 2017 and now recommends that all women aged between 25 and 74 years have a cervical screening test every five years instead of a Pap test every two years. The Cervical Screening Test is more accurate than the Pap test and looks for the types of human papillomavirus (HPV) which can cause cells to change and, in some cases, cause cervical cancer.
Cervical Screening tests can be performed by GPs and Nurses from General Practices, Community/Women’s Health Centres, Family Planning Centres, Sexual Health Clinics, Aboriginal Medical Service and Gynaecologist/Specialist Clinics.
General Practices can register as a cervical screening provider to let women in your area know that you provide Cervical Screening Tests by including your details in the Cervical Screening Test provider directory. If you need to update your provider details please forward the changes to firstname.lastname@example.org.
Key Changes to the National Cervical Screening Program – February 2021
Changes to the Guidelines for the clinical management of women at Intermediate Risk of cervical cancer will come into effect from Monday 1 February 2021.
This follows the Cancer Council Australia Clinical Guidelines working party review of national data from the first two years of the renewed program.
A review of the national clinical program data shows that women at Intermediate risk whose follow-up test is HPV (not-16/18) positive, Liquid Based Cytology prediction negative, possible or low grade squamous intraepithelial lesion will have a low likelihood of histologically-confirmed high grade squamous intraepithelial lesion (CIN2/3) or worse.
Please note that it is now recommended that:
Women with a 12-month follow up HPV (not-16/18) result with LBC prediction negative, pLSIL or LSIL (Intermediate risk result) should be recommended to undertake a further HPV follow up test in 12 months’ time following their previous HPV test instead of referral to colposcopy.
Some groups of women may be at higher risk of harbouring a high-grade abnormality and should be referred to colposcopy if HPV is detected at 12 months, regardless of the LBC result. These include:
- Women two or more years overdue for screening at the time of the initial screen
- Women who identify as being of Aboriginal or Torres Strait Islander
- Women aged 50 years or older
The Cervical Screening Pathway flowchart has now been revised.
Find out more:
Key Changes to the National Cervical Screening Program – December 2017
- The Pap test has been replaced by a new Cervical Screening Test.
- The time between tests has changed from two to five years.
- Screening age has changed from 18 - 69 years to 25 - 74 years.
- Healthcare providers still perform a vaginal speculum examination and take a cervical sample, but the sample medium is liquid-based for partial HPV genotyping
- Participants who have been vaccinated against HPV need to have regular cervical screening as the vaccine does not protect against all oncogenic HPV types
- New MBS Item numbers for Cervical Screening in General Practice
- The self-collection option has been deferred until further notice
- Updates to practice software - install all updates as required to ensure changes to MBS Item numbers.
- Practice staff will need to manually adjust recall and reminder systems as per practice policy
More information on free CPD training; educational resources and information pack are available on the Department of Health's website.
For support contact National Cervical Screening Program on 13 15 56 or email@example.com.
The National Cancer Screening Register
The National Cancer Screening Register (NCSR) supports the operations of the National Cervical Screening Program (NCSP) by providing a secure, confidential database of screening records.
This new Register has replaced the Pap test registers within states and territories, providing a national database of screening records for cervical screening.
The NCSR will also support the National Bowel Cancer Screening Program, meaning that each person who participates in both cervical and bowel cancer screening will have a single record.